← FDA Drug Approvals (Drugs@FDA)

PIPERACILLIN AND TAZOBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2021-02-16

Drug application

FDA Application #

ANDA208675

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIPERACILLIN AND TAZOBACTAM

Generic name

PIPERACILLIN SODIUM, TAZOBACTAM SODIUM

Active ingredients

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2021-02-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown